Questions? Chat with the founder on WhatsApp

Chat with the founder on WhatsApp
Arthneeti
HomeRankingsIPOScreenerInstitutions
HomeRankingsIPOScreenerInstitutions
Colgate-PalmolivQ1 FY27Personal Products
Home/Stocks/Colgate-Palmoliv/Q1 FY27

Colgate-Palmoliv Q1 FY27 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹1,866P/E: 37.5Market Cap: ₹51.4K CrSector: Personal Products

Management growth scorecard

Revenue

Category 3

Margin

Category 4

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3
  • →Colgate-Palmolive India expects continued good growth, balancing price, volume, and premium mix rather than relying solely on pricing (Page 20, 21, 29).
  • →Premium segment is a key growth driver, growing 6 times faster than the market; significant opportunity remains as only 19% of toothpaste is currently premium priced (above 140 index) vs. a potential 40-60% (Page 20, 21).
  • →E-commerce and quick commerce are expanding premium product discovery and penetration, supporting higher margin growth (Page 18).
  • →Growth in rural penetration (e.g., increase in daily brushing) and urban city-to-city corridor expansion also support volume growth (Pages 18, 28).
  • →Brand investment and advertising, especially in premium, will increase to sustain and accelerate growth; advertising spend on premium is disproportionately high (50-60% of turnover) (Pages 12, 26, 27).
  • →Pricing increases will be calibrated and spaced out to protect vulnerable consumers, ensuring value packs remain accessible amid inflation (Page 29).

Margin guidance

Category 4
  • →Colgate-Palmolive (India) aims to sustain double-digit growth in earnings, focusing on a balanced mix of volume, premiumisation (mix), and pricing.
  • →Premium segment growth is strong, expanding at around 6X the core brands, driving higher ASPs and contributing significantly to profits.
  • →Advertising and promotion (A&P) spends are increasing, particularly towards premium brands, supporting accelerated growth but may moderate short-term EBITDA margins.
  • →Gross margins are expected to remain stable (around 69%-70%) due to ongoing efficiencies and favorable product mix.
  • →Operating margins may moderate slightly from FY26 levels as the company invests more in brand building and premiumisation.
  • →The strategy focuses on reinvesting margin savings into marketing to fuel growth, accepting short-term margin pressure for long-term value creation.
  • →Consistent dividend payouts and strong cash generation support stable shareholder returns.

3 more insights locked — sign up free to unlock

Fundraise plans

  • →There is no mention of any current or planned new fundraising through debt or equity in the transcript.
  • →The company highlights strong cash generation, efficient working capital management, and consistent dividend payouts.
  • →Cash flow from operations continues to improve, with negative working capital at -15% of sales in FY '26, freeing up cash for CapEx or dividends.
  • →No indication of raising external funds as the company focuses on reinvesting savings and profits into business growth, particularly premium portfolio expansion.
  • →The management emphasizes maintaining strong governance and value creation without signaling any fundraising plans.

Order book

The provided transcript from the Colgate-Palmolive (India) Limited Investor Day 2026 does not contain any specific information regarding the current or expected order book or pending orders. The discussion mainly focuses on topics such as premiumization, distribution, advertising spend, rural and urban market dynamics, pricing strategy, and growth outlook. Therefore, there is no data available on: - Current order book status - Expected order book volumes - Pending orders If you need detailed order book information, it may be available in other company filings or reports not included in this transcript.

Capex plans

Yes
  • →Sensodyne is planning a significant capex of ₹2,000 crore, signaling a strong investment in the premium whitening toothpaste category (Page 15).
  • →The company is focused on premiumisation, channel expansion including e-commerce and D2C, and investing heavily in advertising and promotions to drive growth (Pages 14, 31).
  • →There is no explicit mention of immediate large-scale new product launches or new portfolio expansions, with a focus instead on timing and right strategic moves for future international brands entry (Page 22).
  • →Colgate-Palmolive is also investing in advertising at a high level (~16% of sales), with over 50-60% advertising investment geared towards premium products to fuel growth (Page 26).
  • →Sustained investment is evident in ongoing consumer outreach programs (e.g., Bright Smiles Bright Future) which are ring-fenced and growing yearly to improve oral health awareness (Page 26).

How does Colgate-Palmoliv rank vs peers in Personal Products?

Pro feature
1Colgate-Palmoliv
Rev 3Mar 4
2Personal Products Company A
Rev 1Mar 2
3Personal Products Company B
Rev 2Mar 1
4Personal Products Company C
Rev 2Mar 3

See full Personal Products sector rankings

How does Colgate-Palmoliv rank in Personal Products?

Compare Colgate-Palmoliv against every Personal Products company (Q1 FY27) on revenue, margins and earnings-call signals.

View Personal Products leaderboard →

Related research

Read the full Q1 FY27 earnings insight — Colgate-Palmoliv

Other quarters — Colgate-Palmoliv

Q4 FY26Q4 FY25Q2 FY25Q4 FY24Q1 FY24Q4 FY23Q2 FY23Q4 FY22Q4 FY21Q4 FY20Q4 FY18

Personal Products peers

Cupid Ltd · Q3 FY24Dabur India · Q1 FY27Emami · Q1 FY27Gillette India · Q4 FY26Godrej Consumer · Q1 FY27
Colgate-Palmoliv full stock analysisPersonal Products sectorEarnings call directoryRankings dashboard

Questions about this analysis? Chat directly with the founder — real answers about the research, not a support bot.

WhatsApp the founder

Research team or advisory firm? Get earnings-call intelligence and ranking history as research inputs for your firm.

For Institutions

Arthneeti AI

AI-powered stock analysis from earnings call transcripts. Helping Indian investors make smarter decisions with data-driven insights.

Analysis

  • Stock Rankings
  • Sectors
  • Compare Stocks
  • IPO Dashboard
  • Stock Screener
  • Earnings Call Analysis
  • Stocks Under ₹500
  • Multibaggers

Tools

  • MF Overlap Checker
  • SIP Calculator
  • CAGR Calculator
  • FD vs Equity
  • All Calculators

Resources

  • Blog
  • Weekly Digest
  • Portfolio Analysis
  • Build Portfolio
  • Earnings Calendar
  • Q1 FY27 Earnings Hub

Company

  • Pricing
  • How Our Analysis Works
  • For Institutions
  • Terms of Service
  • Privacy Policy

Compare

  • vs Screener.in
  • vs Trendlyne
  • vs Tickertape
  • vs Moneycontrol Pro
+91 90841 32575 support@arthneeti.com Bengaluru, India

© 2026 Arthneeti AI. All rights reserved.

AI-analyzed data from 1,500+ company earnings calls

Continue your research

What Colgate-Palmoliv's management said in earlier quarters

  • Q1 FY27 earnings call analysis →
  • Q4 FY25 earnings call analysis →
  • Q4 FY26 earnings call analysis →

Others in Personal Products this season

  • Dabur India (Q1 FY27)

    The company remains confident about maintaining 14%-15% PAT (profit after tax) growth at consolidated level if double-digit top-line growth continues. Key…

  • Emami (Q1 FY27)

    Domestic core business grew ~6% in Q1 FY27; hair care at 11%, skin care at 3% (Rajesh Sharma, pg 13). Key concall takeaways from Emami's Q1 FY27 earnings call…

  • Godrej Consumer (Q1 FY27)

    The company reported strong broad-based revenue growth of 19% YoY and volume growth of 9%, reflecting healthy demand. Key concall takeaways from Godrej…

  • Honasa Consumer (Q1 FY27)

    Q1 FY27 saw 32% revenue growth and 30.5% volume growth, indicating strong momentum. Key concall takeaways from Honasa Consumer's Q1 FY27 earnings call — and…

Compare:vs Godrej Consumervs Dabur Indiavs Cupid Ltd